Cosmo Bio Company,Limited
3386
Rank in Stocks
#23202
Cosmo Bio Company, Limited is a key player in the life science research sector,... Cosmo Bio Company, Limited is a key player in the life science research sector, involved in the global import, export, manufacturing, marketing, and distribution of essential biotools. Their extensive product line includes biochemical reagents, specialized kits, scientific instruments, analytical software, and diagnostic products. Among their research reagents, they offer a wide spectrum such as antibodies, antigens, bioactive substances, enzymes, peptides, amino acids, various chemicals, carbohydrates, lipids, and components derived from viruses and bacteria. They also provide crucial detection reagents, cell and tissue culture systems, and gene analysis solutions. In terms of instrumentation, Cosmo Bio supplies electrophoresis apparatuses, cell culture labware, gene manipulation systems, and data analysis software. Beyond products, the company delivers valuable services like drug discovery support, custom research, and clinical diagnostics. A significant part of their operation involves the development and manufacturing of proprietary cell and cell culture products. This includes a range of specialized cells such as adipose tissue, bone, cartilage, tooth, pancreas, liver function, cardiovascular, immune, and mesenchymal stem cells, in addition to feeder cells, tumor cell lines, coating reagents, and macrophage-related products. They also produce various assay kits for measurement, staining, detection, and purification. Furthermore, they offer specialized biotechnology research equipment, including constant-temperature transport containers, aluminum block heat insulation devices, and dew condensation prevention glass plates, alongside consigned services for custom peptide synthesis and antibody production. Serving a diverse clientele of laboratories, research institutes, and life science education and testing organizations, Cosmo Bio distributes its products through its own outlets in Japan and an international network of sales agents. The company was founded in Tokyo, Japan, in 1978, where its headquarters remain.
Share Price
$7.69
Last synced: 2026-11-13
Market Cap
$43.83M
Change (1 day)
-0.12%
Change (1 year)
-12.01%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Cosmo Bio Company,Limited (3386)
Category
Healthcare
Operating Margin for Cosmo Bio Company,Limited (3386)
Operating Margin as of November 2026 TTM: 2.86%
According to Cosmo Bio Company,Limited's latest financial reports, its current operating margin (TTM) is 2.86%. At the end of 2025 the company had an operating margin of 3.18%.
Operating Margin history for Cosmo Bio Company,Limited from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 2.86% | -10.06% |
| 2025 | 3.18% | 0.32% |
| 2024 | 3.17% | -42.99% |
| 2023 | 5.56% | -34.89% |
| 2022 | 8.54% | -24.76% |
| 2021 | 11.35% | 22.17% |
| 2020 | 9.29% | 73.64% |
| 2019 | 5.35% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 17.98% | -93.71% |
US
|
|
| 20.38% | -92.87% |
US
|
|
| 43.02% | -84.96% |
CN
|
|
| 32.30% | -88.71% |
US
|
|
| 22.23% | -92.23% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Cosmo Bio Company,Limited's operating margin
What is Cosmo Bio Company,Limited's operating margin?
Cosmo Bio Company,Limited's operating margin is 2.86%, as of Nov 2026.
What was Cosmo Bio Company,Limited's operating margin in 2025?
In 2025, Cosmo Bio Company,Limited's operating margin was 3.18%, compared with 3.17% in 2024.
How has Cosmo Bio Company,Limited's operating margin changed since 2020?
From 2020 to 2025, Cosmo Bio Company,Limited's operating margin was highest in 2021 (11.35%) and lowest in 2024 (3.17%).
How does Cosmo Bio Company,Limited's operating margin compare with similar companies?
Cosmo Bio Company,Limited's operating margin (2.86%) is lower than that of all 5 similar companies listed above. The highest among them is WuXi AppTec Co., Ltd., with 43.02%.